IP Library Granted Patent US 10,675,381
Granted Patent B2
US 10,675,381 · App. 15/758,511 · Granted Jun 9, 2020

Decellularized biomaterial and method for formation

Inventors: Christopher Fernandez (Clifton, NJ); Jeremy Mercuri (Piedmont, SC)
Assignee: Clemson University Research Foundation
A61L27/3687A61F2/442A61L27/3612A61L27/3658A61L27/3683A61L27/3691A61L27/3834A61L27/3856C12N5/0018A61L2430/06A61L2430/38C12N2533/90C12N2537/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,675,381
App. No.
15/758,511
Granted
Jun 9, 2020
Kind
B2
Abstract

Methods for developing a decellularized tissue and biomaterials for use as biomimetic grafts or in vitro cellular scaffolds formed with the decellularized tissue are described. The biomaterials are particularly well suited for use as an intervertebral disc graft. The decellularized tissue is formed from an intervertebral disc source tissue and can be substantially decellularized and substantially free of potential immunogenic material (e.g., DNA and RNA), while maintaining ECM materials including both glycosaminoglycan and collagen.

Claims (10)

1. A biomaterial comprising a decellularized bovine intervertebral disc tissue, the decellularized bovine intervertebral disc tissue being substantially free of cell nuclei of a source bovine intervertebral disc tissue, the decellularized bovine intervertebral disc tissue comprising decellularized nucleus pulposus tissue, the decellularized nucleus pulposus tissue having a glycosaminoglycan content of about 200 micrograms or greater per milligram dry weight of the decellularized nucleus pulposus tissue and having a nucleic acid content of about 50 nanograms or less per milligram dry weight of the decellularized nucleus pulposus tissue.

2. The biomaterial of claim 1 , the decellularized intervertebral disc tissue having a ratio of glycosaminoglycan content to hydroxyproline content of from about 10:1 to about 25:1.

3. The biomaterial of claim 1 , further comprising extrinsic cells.

4. The biomaterial of claim 3 , wherein the extrinsic cells comprise stem cells.

5. The biomaterial of claim 1 , wherein one or more components of the decellularized intervertebral disc tissue is crosslinked.

6. The biomaterial of claim 1 , wherein the biomaterial is an implantable graft material.

7. The biomaterial of claim 6 , wherein the implantable graft material is an implantable intervertebral disc graft.

8. The biomaterial of claim 1 , wherein the biomaterial is an in vitro cellular scaffold material.

9. The biomaterial of claim 1 , further comprising annulus fibrosus tissue.

10. The biomaterial of claim 1 , wherein the biomaterial comprises an entire intervertebral disc.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2018
From: CLEMSON UNIVERSITY
To: CLEMSON UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 047165/0510 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2018
From: CLEMSON UNIVERSITY
To: CLEMSON UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 047165/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2018
From: FERNANDEZ, CHRISTOPHER; MERCURI, JEREMY
To: CLEMSON UNIVERSITY
Reel/Frame 047045/0577 →
Continuity (2)
Provisional Application 62215475 · Sep 8, 2015
Related Publication 20180256784A1 · Sep 13, 2018